Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Bafna Pharmaceuticals Statistics

Total Valuation

NSE:BAFNAPH has a market cap or net worth of INR 2.78 billion. The enterprise value is 3.10 billion.

Market Cap	2.78B
Enterprise Value	3.10B

Important Dates

The next estimated earnings date is Monday, February 9, 2026.

Earnings Date	Feb 9, 2026
Ex-Dividend Date	n/a

Share Statistics

NSE:BAFNAPH has 23.66 million shares outstanding. The number of shares has increased by 0.04% in one year.

Current Share Class	23.66M
Shares Outstanding	23.66M
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	-0.11%
Owned by Insiders (%)	4.97%
Owned by Institutions (%)	4.36%
Float	3.34M

Valuation Ratios

The trailing PE ratio is 31.64.

PE Ratio	31.64
Forward PE	n/a
PS Ratio	1.95
PB Ratio	3.04
P/TBV Ratio	3.04
P/FCF Ratio	n/a
P/OCF Ratio	17.97
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.31, with an EV/FCF ratio of -22.85.

EV / Earnings	35.30
EV / Sales	2.18
EV / EBITDA	19.31
EV / EBIT	27.35
EV / FCF	-22.85

Financial Position

The company has a current ratio of 1.67, with a Debt / Equity ratio of 0.36.

Current Ratio	1.67
Quick Ratio	0.69
Debt / Equity	0.36
Debt / EBITDA	2.02
Debt / FCF	-2.39
Interest Coverage	3.70

Financial Efficiency

Return on equity (ROE) is 10.08% and return on invested capital (ROIC) is 9.72%.

Return on Equity (ROE)	10.08%
Return on Assets (ROA)	4.80%
Return on Invested Capital (ROIC)	9.72%
Return on Capital Employed (ROCE)	10.03%
Weighted Average Cost of Capital (WACC)	5.28%
Revenue Per Employee	3.51M
Profits Per Employee	216,062
Employee Count	406
Asset Turnover	0.97
Inventory Turnover	3.29

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.97% in the last 52 weeks. The beta is 0.14, so NSE:BAFNAPH's price volatility has been lower than the market average.

Beta (5Y)	0.14
52-Week Price Change	+52.97%
50-Day Moving Average	148.39
200-Day Moving Average	114.29
Relative Strength Index (RSI)	37.32
Average Volume (20 Days)	3,462

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:BAFNAPH had revenue of INR 1.42 billion and earned 87.72 million in profits. Earnings per share was 3.71.

Revenue	1.42B
Gross Profit	462.74M
Operating Income	113.24M
Pretax Income	87.72M
Net Income	87.72M
EBITDA	160.37M
EBIT	113.24M
Earnings Per Share (EPS)	3.71

Balance Sheet

The company has 2.54 million in cash and 324.03 million in debt, with a net cash position of -321.48 million or -13.59 per share.

Cash & Cash Equivalents	2.54M
Total Debt	324.03M
Net Cash	-321.48M
Net Cash Per Share	-13.59
Equity (Book Value)	912.28M
Book Value Per Share	38.54
Working Capital	322.50M

Cash Flow

In the last 12 months, operating cash flow was 154.41 million and capital expenditures -289.93 million, giving a free cash flow of -135.53 million.

Operating Cash Flow	154.41M
Capital Expenditures	-289.93M
Free Cash Flow	-135.53M
FCF Per Share	-5.73

Margins

Gross margin is 32.51%, with operating and profit margins of 7.96% and 6.16%.

Gross Margin	32.51%
Operating Margin	7.96%
Pretax Margin	6.16%
Profit Margin	6.16%
EBITDA Margin	11.27%
EBIT Margin	7.96%
FCF Margin	n/a

Dividends & Yields

NSE:BAFNAPH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.04%
Shareholder Yield	-0.04%
Earnings Yield	3.16%
FCF Yield	-4.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5